Alliance and Innovation in Aesthetic Medicine with Dr. Tufet and Renophase® Laboratories Paris
In an unprecedented collaboration, Dr. Jaume Tufet, founder of Clínica Tufet, and Dr. Michèle Eymard, founder and CEO of Renophase® Laboratories, two leading figures in health and aesthetic medicine in Europe, have integrated the latest technology in aesthetic dermatology and the most recent scientific advances, redefining the approach to rejuvenation and skin care in Spain. This alliance leads a new vision of traditional aesthetic medicine by introducing a regenerative medicine approach focused on the precision of cellular longevity.
Integrative Renophase® and Its Dermatology Treatments
A new trend that is here to stay in aesthetic medicine is cellular longevity treatments, aimed at addressing the root cause of skin cell dysfunction. Only by restoring skin cell health can we improve their function, homeostasis, reduce signs of chrono- and photoaging (premature wrinkles, hyperpigmentation, loss of firmness, dehydration, and skin hypersensitivity), and optimize their self-defense.
Another important aspect of this treatment approach is its integrative nature, meaning it utilizes different innovative and non-invasive medical technologies that, within the same session, allow for amplified synergies.
In clinical practice, a session consists of an Integrative Dermatology Renophase® treatment, including: • Molecules that restore the skin’s normal exfoliation • Biological precursors • Pre-programmed biomimetic molecules • Antioxidants and detoxifying agents • Photo-regeneration (LED)
The results are visible from the first session, cumulative, and long-lasting. Four sessions are recommended, one every 15 days, based on international clinical cases.
You can view the results gallery on the Dr. Tufet Renophase site: https://renophase.fr/tufet/
The collaboration between Dr. Tufet and Renophase® Laboratories is not only focused on enhancing beauty standards but also on promoting health and addressing dermatological challenges such as rosacea or melasma. By adopting a revolutionary approach, they have created aesthetic treatments based on salutogenesis, one of the main research areas of Renophase® Laboratories. This discipline is dedicated to fostering factors that promote health, as opposed to internal factors that contribute to disease development.
Every day, cells produce a large number of toxins and are responsible for recycling and transforming them. However, over time, the efficiency of this function declines, and cells lose their regenerative capacity. Renophase® and Dr. Tufet offer cellular longevity treatments that introduce biological precursors designed to stimulate the elimination of toxins by skin cells, thus unleashing their exceptional natural self-regeneration ability.
To learn more or book an appointment, visit the Dr. Tufet Renophase site: https://renophase.fr/tufet/